| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |